| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
10,948 |
9,800 |
$1.81M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,353 |
6,005 |
$803K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,413 |
2,023 |
$209K |
| 71046 |
Radiologic examination, chest; 2 views |
1,604 |
1,391 |
$194K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,236 |
909 |
$153K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,734 |
3,324 |
$147K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,084 |
1,811 |
$145K |
| 80053 |
Comprehensive metabolic panel |
15,993 |
13,345 |
$108K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,860 |
1,451 |
$100K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
14,460 |
12,052 |
$69K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,256 |
1,762 |
$61K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
321 |
301 |
$48K |
| 71045 |
Radiologic examination, chest; single view |
240 |
204 |
$26K |
| 87634 |
|
419 |
367 |
$23K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
76 |
56 |
$14K |
| 80061 |
Lipid panel |
1,461 |
1,298 |
$11K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
183 |
148 |
$11K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
742 |
667 |
$10K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
792 |
704 |
$10K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
56 |
53 |
$10K |
| 83690 |
|
1,898 |
1,480 |
$9K |
| 36415 |
Collection of venous blood by venipuncture |
2,740 |
2,258 |
$8K |
| 85027 |
|
1,092 |
848 |
$7K |
| 81001 |
|
3,226 |
2,682 |
$7K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,341 |
1,179 |
$7K |
| 84484 |
|
988 |
658 |
$6K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
631 |
451 |
$6K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
47 |
37 |
$6K |
| 80306 |
|
775 |
611 |
$6K |
| 70450 |
Computed tomography, head or brain; without contrast material |
59 |
39 |
$5K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
167 |
126 |
$5K |
| 83880 |
|
352 |
254 |
$4K |
| 84443 |
Thyroid stimulating hormone (TSH) |
357 |
323 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
347 |
287 |
$4K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
963 |
793 |
$3K |
| 74018 |
|
14 |
12 |
$3K |
| 82728 |
|
237 |
204 |
$2K |
| 83735 |
|
467 |
377 |
$2K |
| 87088 |
|
504 |
415 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
50 |
44 |
$1K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
50 |
44 |
$979.80 |
| 83605 |
|
118 |
87 |
$945.82 |
| 84702 |
|
100 |
65 |
$819.72 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
36 |
31 |
$765.29 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
39 |
36 |
$730.63 |
| 86803 |
|
55 |
50 |
$554.69 |
| 81025 |
|
98 |
82 |
$540.48 |
| 87510 |
|
43 |
38 |
$516.35 |
| 87480 |
|
43 |
38 |
$511.57 |
| 87660 |
|
43 |
38 |
$505.95 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
21 |
17 |
$448.56 |
| 86140 |
|
166 |
139 |
$422.44 |
| 87481 |
|
21 |
17 |
$319.59 |
| 84144 |
|
19 |
13 |
$292.04 |
| 85730 |
|
103 |
72 |
$97.86 |
| 87430 |
|
42 |
31 |
$79.15 |
| 83550 |
|
17 |
12 |
$75.16 |
| 85379 |
|
21 |
14 |
$68.22 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
15 |
14 |
$67.44 |
| 85610 |
|
104 |
72 |
$66.73 |
| 81003 |
|
40 |
37 |
$56.25 |
| 83540 |
|
17 |
12 |
$55.64 |
| 82950 |
|
14 |
13 |
$50.75 |
| 87081 |
|
24 |
18 |
$16.68 |
| A9270 |
Non-covered item or service |
29 |
25 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
12 |
12 |
$0.00 |